Not Tagged
Exscientia
['biomarker']
next #aacr23 poster (2151) on our #biomarker signature to predict patients likely to benefit from exscientia s clinical a2ar antagonist "'546" combined with #checkpointinhibitors. watch the great s poster presentation online! $exai 
Chief Business Officer at $EXAI https://t.co/eMa9eUvq9m. Drug inventor, biotech builder, PhD computational chemist, bike racer, ex-Oxford rower & LFC fan!